{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:55:32Z","timestamp":1786121732063,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["# 23K07815"],"award-info":[{"award-number":["# 23K07815"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003790","name":"Hiroshima University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["#19pc0101041h0001"],"award-info":[{"award-number":["#19pc0101041h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcyt.2026.102911","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:26:42Z","timestamp":1779380802000},"page":"102911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platinum TALEN-mediated nonviral gene editing facilitates clinical-scale production of cancer antigen-reactive T cells"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0781-5141","authenticated-orcid":false,"given":"Kayo","family":"Toishigawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-7560","authenticated-orcid":false,"given":"Kenta","family":"Magoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Edahiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5034-3699","authenticated-orcid":false,"given":"Hiroshi","family":"Ureshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-6151","authenticated-orcid":false,"given":"Takero","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-1563","authenticated-orcid":false,"given":"Tetsushi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6516-2903","authenticated-orcid":false,"given":"Takashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4066","authenticated-orcid":false,"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102911_bib0001","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tevas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102911_bib0002","doi-asserted-by":"crossref","first-page":"eaaj2013","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.jcyt.2026.102911_bib0003","doi-asserted-by":"crossref","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.jcyt.2026.102911_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102911_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2026.102911_bib0006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2026.102911_bib0007","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0008","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.3910","article-title":"NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma","volume":"21","author":"Rapoport","year":"2015","journal-title":"Nat Med."},{"key":"10.1016\/j.jcyt.2026.102911_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003811","article-title":"NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome","volume":"10","author":"Ishihara","year":"2022","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.jcyt.2026.102911_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood-2006-03-013318","article-title":"Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex","volume":"109","author":"Heemskerk","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.jcyt.2026.102911_bib0011","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nm.2128","article-title":"Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy","volume":"16","author":"Bendle","year":"2010","journal-title":"Nat Med."},{"key":"10.1016\/j.jcyt.2026.102911_bib0012","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO-24-01466","article-title":"Letetresgene autoleucel in advanced\/metastatic myxoid\/round cell liposarcoma","volume":"43","author":"D'Angelo","year":"2025","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nm.2700","article-title":"Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer","volume":"18","author":"Provasi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102911_bib0014","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/gt.2014.26","article-title":"TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer","volume":"21","author":"Berdien","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.jcyt.2026.102911_bib0015","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41551-019-0409-0","article-title":"Orthotopic replacement of T-cell receptor \u03b1- and \u03b2- chain with preservation of near-physiological T-cell function","volume":"3","author":"Schober","year":"2019","journal-title":"Nat Biomed Eng."},{"issue":"8","key":"10.1016\/j.jcyt.2026.102911_bib0016","article-title":"Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy","volume":"2","author":"M\u00fcller","year":"2021","journal-title":"Cell Rep Med."},{"key":"10.1016\/j.jcyt.2026.102911_bib0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming of human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102911_bib0018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tcb.2013.04.003","article-title":"TAL effectors: highly adaptable phytobacterial virulence factors and readily engineered DNA-targeting proteins","volume":"23","author":"Doyle","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-0716-3016-7_2","article-title":"Updated overview of TALEN construction systems","volume":"2637","author":"Sakuma","year":"2023","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nbt.3127","article-title":"Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0021","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1038\/srep03379","article-title":"Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity","volume":"3","author":"Sakuma","year":"2013","journal-title":"Sci Rep."},{"key":"10.1016\/j.jcyt.2026.102911_bib0022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrd.22591","article-title":"Efficient modification of the myostatin gene in porcine somatic cells and generation of knockout piglets","volume":"83","author":"Rao","year":"2016","journal-title":"Mol Reprod Dev."},{"key":"10.1016\/j.jcyt.2026.102911_bib0023","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.jcyt.2026.102911_bib0024","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 based immunotherapy of cancer: current perspectives","volume":"9","author":"Thomas","year":"2018","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.jcyt.2026.102911_bib0025","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.4049\/jimmunol.180.9.6116","article-title":"Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions","volume":"180","author":"Robbins","year":"2008","journal-title":"J Immunol."},{"issue":"1","key":"10.1016\/j.jcyt.2026.102911_bib0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00163961","article-title":"The extent of the human germline T-cell receptor V beta gene segment repertoire","volume":"40","author":"Wei","year":"1994","journal-title":"Immunogenetics."},{"issue":"Web Server issue","key":"10.1016\/j.jcyt.2026.102911_bib0027","doi-asserted-by":"crossref","first-page":"W117","DOI":"10.1093\/nar\/gks608","article-title":"TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction","volume":"40","author":"Doyle","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.jcyt.2026.102911_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt1326","article-title":"An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage","volume":"42","author":"Fine","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.jcyt.2026.102911_bib0029","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1101\/gr.176701.114","article-title":"OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines","volume":"24","author":"Schmid-Burgk","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.jcyt.2026.102911_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12938-025-01452-y","article-title":"Evaluating cell viability assessment techniques: a comparative study of flow cytometry and fluorescence microscopy in response to bioactive glass exposure","volume":"24","author":"Samuel","year":"2025","journal-title":"BioMed Eng OnLine"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102911_bib0031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.jcyt.2026.102911_bib0032","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1093\/nar\/gky571","article-title":"How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing","volume":"46","author":"Bollen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jcyt.2026.102911_bib0033","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s42003-018-0054-2","article-title":"Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template","volume":"1","author":"Aird","year":"2018","journal-title":"Commun Biol."},{"issue":"5","key":"10.1016\/j.jcyt.2026.102911_bib0034","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211530","article-title":"High efficiency nonviral CRISPR\/Cas9-mediated gene editing of human T cells using plasmid donor DNA","volume":"219","author":"Oh","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2026.102911_bib0035","first-page":"213","article-title":"Genome-wide specificity of highly efficient TALENs and CRISPR\/Cas9 for T cell receptor modification","volume":"4","author":"Knipping","year":"2017","journal-title":"Mol Ther."},{"issue":"6","key":"10.1016\/j.jcyt.2026.102911_bib0036","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell."},{"issue":"1","key":"10.1016\/j.jcyt.2026.102911_bib0037","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-023-40901-x","article-title":"Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing","volume":"14","author":"Tsai","year":"2023","journal-title":"Nat Commun."},{"issue":"10","key":"10.1016\/j.jcyt.2026.102911_bib0038","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nbt.2959","article-title":"Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping","volume":"32","author":"de Vree","year":"2014","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2023.1130736","article-title":"T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds","volume":"5","author":"Rhiel","year":"2023","journal-title":"Front Genome Ed."},{"key":"10.1016\/j.jcyt.2026.102911_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fimmu.2020.00702","article-title":"Prolonged persistence of chimeric antigen receptor (CAR) T cell in adoptive cancer immunotherapy: challenges and ways forward","volume":"11","author":"Jafarzadeh","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0041","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41591-024-03478-6","article-title":"Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies","volume":"31","author":"Jadlowsky","year":"2025","journal-title":"Nat Med."},{"key":"10.1016\/j.jcyt.2026.102911_bib0042","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature."},{"key":"10.1016\/j.jcyt.2026.102911_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-025-01378-4","article-title":"Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy","volume":"23","author":"Chen","year":"2026","journal-title":"Cell Mol Immunol."},{"key":"10.1016\/j.jcyt.2026.102911_bib0044","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.2024026758","article-title":"HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma","volume":"145","author":"Caballero","year":"2025","journal-title":"Blood."},{"key":"10.1016\/j.jcyt.2026.102911_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41587-019-0325-6","article-title":"Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency","volume":"38","author":"Nguyen","year":"2020","journal-title":"Nat Biotechnol."}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:52:27Z","timestamp":1786081947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1465324926008728"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102911","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platinum TALEN-mediated nonviral gene editing facilitates clinical-scale production of cancer antigen-reactive T cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102911"}}